β-galactosidase activity as a marker of senescence in primary cultures of the ovarian surface epithelium;Actividad de la β-galactosidasa como marcador de senescencia en cultivos primarios del epitelio superficial del ovario

Investigacion Clinica

Volumn 51, Issue 3, 2010, Pages 351-367

  Chuaire Noack, Lilian ^a   Rondón Lagos, Sandra ^a   Sánchez Corredor, Magda ^a   Ibáñez Pinilla, Milcíades ^a   Ramírez Clavijo, Sandra ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

galactosidase; Biomarker; Ovarian epithelial cells; Replicative senescence

Indexed keywords

BETA GALACTOSIDASE;

ARTICLE; CELL CULTURE; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CELL; SENESCENCE;

ADOLESCENT; ADULT; BETA-GALACTOSIDASE; CELL AGING; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; HUMANS; MIDDLE AGED; OVARY; YOUNG ADULT;

EID: 78650437743     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Auersperg N, Wong AS, Choi K, Kang SK, Leung PCK. Ovarian surface epithelium: Biology, Endocrinology and Pathology. Endocr Rev 2001; 22:255-288.
2. Wright JW, Toth-Fejel S, Stouffer RL, Rodland KD. Proliferation of rhesus ovarian surface epithelial cells in culture: lack of mitogenic response to steroid or gonadotropic hormones. Endocrinology 2002; 143:2198-2207. (Pubitemid 34521565)
3. Daikoku T, Wang D, Tranguch S, Morrow JD, Orsulic S, DuBois RN, Dey SK. Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res 2005; 65:3735-3744. (Pubitemid 40616351)
4. Campisi J. Aging, tumor suppression and cancer: High-wire act! Mech Ageing Dev 2005; 126: 51-58.
5. Herbst AL. The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. Am J Obstet Gynecol 1994; 170:1099-1105.
6. Wong AS, Auersperg N. Ovarian surface epithelium: Family history and early events in ovarian cancer. Reprod Biol Endocrinol. 2003:1-70. En: http://www.RBEj.com/content/ 1/1/70 (Fecha último acceso: febrero 26 de 2010).
7. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92:9363-9367.
8. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4:1798-1806.
9. Bronstein I, Fortin J, Stanley PE, Stewart GS, Kricka LJ. Chemoluminiscent and bioluminescent reporter gene assays. Anal Biochem 1994; 219:169-181. (Pubitemid 24206794)
10. López NE, Martínez CM, Konigsberg M. La senescencia replicativa como una respuesta celular al estrés. Rev Educ Bioquim 2005; 24:47-53.
11. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, Kleijer WJ, DiMaio D, Hwang ES. Senescence-associated β-galactosidase is lisosomal β-galactosidase. Aging Cell 2006; 5:187-195.
12. Coates SS, Lehnert BE, Sharma S, Kindell SM, Gary RK. Beryllium induces premature senescence in human fibroblasts. J Pharmacol Exp Ther 2007; 322: 70-79. (Pubitemid 46956349)
13. Kurz DJ, Decary S, Hong Y, Erusalimsky JD. Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 2000; 113: 3613-3622.
14. Gerland LM, Peyrol S, Lallemand C, Branche R, Magaud JP, French M. Association of increased autophagic inclusions labeled for β-galactosidase with fibroblastic aging. Exp Gerontol 2003; 38:887-895. (Pubitemid 36952670)
15. Untergasser G, Gander R, Rumpold H, Heinrich E, Plas E, Berger P. TGF-β cytokines increase senescence-associated β-galactosidase activity in human prostate basal cells by supporting differentiation processes, but not cellular senescence. Exp Gerontol 2003; 38:1179-1188. (Pubitemid 37324429)
16. Gossrau R, Lojda Z, Steward PJ. Glycosidase. 1991. En: Histochemistry: theoretical and applied. Stoward PJ, Everson Pearse AG, Eds: 241-279. Churchill Livingston, Edinburgh.
17. Citado por: Maier AB, Westendorp RG, Van Heemst D. β-galactosidase activity as a biomarker of replicative senescence during the course of human fibroblast cultures. Ann NY Acad Sci 2007; 1100:323-332.
18. Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev 2005; 205:147-157. (Pubitemid 40780183)
19. Streit WJ. Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci 2006; 29:506-510.
20. Erusalimsky JD. Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol 2009; 106:326-332.
21. Burton DG. Cellular senescence, ageing and disease, Age 2009; 31:1-9.
22. Dunfield LD, Shepherd TG, Nachtigal MW. Primary culture and mRNA analysis of human ovarian cells. Biol Proced Online 2002; 4:55-65.
23. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585-621.
24. Siemens CH, Auersperg N. Serial propagation of human ovarian surface epithelium in tissue culture. J Cell Physiol 1988; 134: 347-356. (Pubitemid 18092269)
25. Auersperg N, Maines-Bandiera SL Culture and characterization of human ovarian surface epithelium. En: Bartlett JMS (ed) Ovarian Cancer Methods Protocols. Humana Press, Totowa, NJ, 2000 pp 169-173.
26. Shepherd TG, Thériault BL, Campbell EJ, Nachtigal MW. Primary culture of ovarian surface epithelial cells and ascitesderived ovarian cancer cells from patients. Nat Protoc 2006; 1:2643-2649.
27. Campisi J, D'Adda di Fagagna F. Cellular senescence: When bad things happen to good cells. Mol Cell Biol 2007; 8:729-740. (Pubitemid 47312822)
28. Hannah R, Stroke I, Betz N. Beta-glo® assay system: a luminescent Β-galactosidase assay for multiple cell types and media. Cell Notes 2003; 6:16-18. En: www. promega.com. Fecha último acceso: octubre 11 de 2009.
29. Maier AB, Westendorp RG, Van Heemst D. Beta-galactosidase activity as a biomarker of replicative senescence during the course of human fibroblast cultures. Ann N Y Acad Sci 2007; 1100:323-332. (Pubitemid 47092669)
30. Auersperg N, Siemens CH, Myrdal SE. Human ovarian surface epithelium in primary culture. In Vitro 1984; 20:743-755. (Pubitemid 15171896)
31. Wong AS, Leung PC, Maines-Bandiera SL, Auersperg N. Metaplastic changes in cultured human ovarian surface epithelium. In Vitro Cell Dev Biol Anim 1998; 34:668-670.
32. Piek JM, Dorsman JC, Shvarts A, Ansink AC, Massuger LF, Scholten P, van Diest PJ, Dijkstra JC, Weegenaar J, Kenemans P, Verheijen RH. Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma. Gynecol Oncol 2004; 92:819-826. (Pubitemid 38251383)
33. Liton PB, Lin Y, Luna C, Li G, Gonzalez P, Epstein DL. Cultured porcine trabecular meshwork cells display altered lysosomal function when subjected to chronic oxidative stress. Invest Ophthalmol Vis Sci 2008; 49:3961-3969.
34. Liton PB, Lin Y, Gonzalez P, Epstein DL. Potential role of lysosomal dysfunction in the pathogenesis of primary open angle glaucoma. Autophagy 2009; 5:122-124.
35. Ballabio A. Impairment of autophagy in lysosomal storage diseases. Mol Genet Metab 2009; 96:S14.
36. Sharpless NE. Ink4a/Arf links senescence and aging. Exp Gerontol 2004; 39:1751-1759.
37. Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006; 443:453-457. (Pubitemid 44477281)
38. Yang L, Suwa T, Wright WE, Shay JW, Hornsby PJ. Telomere shortening and decline in replicative potential as a function of donor age in human adrenocortical cells. Mech Ageing Dev 2001; 122:1685-1694. (Pubitemid 32835216)
39. Patil CK, Mian S, Campisi J. The thorny path linking cellular senescence to organismal aging. Mech Ageing Dev 2005; 126:1040-1045. (Pubitemid 41258170)
40. Lithgow GJ, Walker GA. Stress resistance as a determinate of C. elegans lifespan. Mech Ageing Dev 2002; 123:765-771.
41. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP. Crucial role of p53-dependent cellular senescence in suppression of PTEN deficient tumorigenesis. Nature 2005; 436:725-730. (Pubitemid 41117277)
42. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters A, Schlegelberger B, Stein H; Doerken B, Jenuwein T, Schmitt CA. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436:660-665. (Pubitemid 41117262)
43. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, Benguria A, Zaballos A, Flores JM, Barbacid M, Beach D, Serrano M. Tumour biology: Senescence in premalignant tumours. Nature 2005; 436:642. (Pubitemid 41117258)
44. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW. A senescence program controlled by p53 and p16ink4a contributes to the outcome of cancer therapy. Cell 2002; 109:335-346. (Pubitemid 34606876)
45. Te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 2002; 62: 1876-1883. (Pubitemid 34408516)
46. Roninson IB. Tumor cell senescence in cancer treatment. Cancer Res 2003; 63:2705-2715. (Pubitemid 36667137)
47. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM Majoor DM, Shay JW, Mooi WJ, Peeper DS. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436:720-724. (Pubitemid 41117276)
48. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biology 2005; 37:961-976. (Pubitemid 40311739)
49. Wright WE, Shay JW. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr Opin Genet Dev 2001; 11: 98-103.
50. Ramsey MR, Sharpless NE. ROS a tumour suppressor? Nat Cell Biol 2006; 8:1213-1215.
51. Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 2002; 34:1401-1414. (Pubitemid 35251811)
52. Campisi J. Cancer and ageing: rival demons? Nature Rev Cancer 2003; 3:339-349.
53. Shay JW, Wright WE. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005; 26:867-874. (Pubitemid 41214314)
54. Dohi, Kojima M, Sato K, Luscher TF. Age-related changes in vascular smooth muscle and endothelium. Drugs Aging 1995; 7:278-291.
55. Burton DG, Giles PJ, Sheerin AN, Smith SK, Lawton JJ, Ostler EL, Rhys-Williams W, Kipling D, Faragher RG. Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification. Exp Gerontol 2009; 44: 659-665.
56. Carnes BA, Staats DO, Sonntag WE. Does senescence give rise to disease? Mech Ageing Dev 2008; 129:693-699.
57. Carnero A. Cellular senescence as a target in cancer control. Curr Canc Ther Rev 2007; 3:3-15.